The introduction of nicotinamide as a nicotine alternative in e-cigarette and smokeless merchandise signifies an important regulatory challenge to the FDA. Nicotinamide does not have nicotinic receptor agonist action and is known to act as a sedative at substantial dosages6. The claims made by Nicotine River, ECBlend, together with other distributo